 |
|
|
| |
Safety, Efficacy, and Pharmacokinetics of Ibalizumab in Treatment-Experienced HIV-1 Infected Patients: a Phase 2b Study
|
| |
| |
Reported by Jules Levin
51st Interscience Conference on Antimicrobial Agents and Chemotherapy
September 17-20, 2011 | Chicago, IL, USA
H. KHANLOU1, J. GATHE2, S. SCHRADER3, W. TOWNER4, S. WEINHEIMER5, S. LEWIS5. 1
AIDS Health Care Fndn., Los Angeles, CA, 2Therapeutic Concepts, Houston, TX, 3Res. Access Network, Houston, TX, 4Kaiser Permanente, Los Angeles, CA, 5TMB USA, Irvine, CA
|
| |
|
|
|
|
|
